nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR3A—myenteric nerve plexus—colon cancer	0.0699	0.14	CbGeAlD
Loxapine—CHRM3—ureter—colon cancer	0.0552	0.11	CbGeAlD
Loxapine—HTR7—myenteric nerve plexus—colon cancer	0.0453	0.0905	CbGeAlD
Loxapine—CHRM3—muscle of abdomen—colon cancer	0.0398	0.0795	CbGeAlD
Loxapine—HTR7—vein—colon cancer	0.0292	0.0583	CbGeAlD
Loxapine—HTR2A—myenteric nerve plexus—colon cancer	0.0282	0.0564	CbGeAlD
Loxapine—HTR2A—vein—colon cancer	0.0182	0.0364	CbGeAlD
Loxapine—Ileus paralytic—Vincristine—colon cancer	0.0151	0.0306	CcSEcCtD
Loxapine—HRH4—bone marrow—colon cancer	0.0148	0.0296	CbGeAlD
Loxapine—Slurred speech—Fluorouracil—colon cancer	0.0136	0.0276	CcSEcCtD
Loxapine—HTR1B—blood vessel—colon cancer	0.012	0.024	CbGeAlD
Loxapine—HTR1D—blood vessel—colon cancer	0.0116	0.0232	CbGeAlD
Loxapine—Akathisia—Irinotecan—colon cancer	0.0115	0.0233	CcSEcCtD
Loxapine—HTR7—endothelium—colon cancer	0.01	0.0201	CbGeAlD
Loxapine—Ileus paralytic—Capecitabine—colon cancer	0.00983	0.0199	CcSEcCtD
Loxapine—HTR7—blood vessel—colon cancer	0.00925	0.0185	CbGeAlD
Loxapine—Chest tightness—Capecitabine—colon cancer	0.00907	0.0184	CcSEcCtD
Loxapine—CHRM5—epithelium—colon cancer	0.00846	0.0169	CbGeAlD
Loxapine—Numbness—Vincristine—colon cancer	0.00787	0.016	CcSEcCtD
Loxapine—Sensory loss—Vincristine—colon cancer	0.00753	0.0153	CcSEcCtD
Loxapine—Numbness—Fluorouracil—colon cancer	0.00734	0.0149	CcSEcCtD
Loxapine—DRD5—lymphoid tissue—colon cancer	0.00727	0.0145	CbGeAlD
Loxapine—ADRA1B—renal system—colon cancer	0.00717	0.0143	CbGeAlD
Loxapine—Sensory loss—Fluorouracil—colon cancer	0.00702	0.0142	CcSEcCtD
Loxapine—HRH2—digestive system—colon cancer	0.00674	0.0135	CbGeAlD
Loxapine—Dysarthria—Irinotecan—colon cancer	0.00672	0.0136	CcSEcCtD
Loxapine—Gait disturbance—Vincristine—colon cancer	0.00668	0.0136	CcSEcCtD
Loxapine—Gait disturbance—Irinotecan—colon cancer	0.00651	0.0132	CcSEcCtD
Loxapine—Dysarthria—Fluorouracil—colon cancer	0.00643	0.013	CcSEcCtD
Loxapine—HTR2A—endothelium—colon cancer	0.00626	0.0125	CbGeAlD
Loxapine—Salivary hypersecretion—Irinotecan—colon cancer	0.00617	0.0125	CcSEcCtD
Loxapine—HTR2A—blood vessel—colon cancer	0.00577	0.0115	CbGeAlD
Loxapine—HTR3A—digestive system—colon cancer	0.0053	0.0106	CbGeAlD
Loxapine—Photosensitivity—Fluorouracil—colon cancer	0.00503	0.0102	CcSEcCtD
Loxapine—HRH2—liver—colon cancer	0.00502	0.01	CbGeAlD
Loxapine—Chest discomfort—Capecitabine—colon cancer	0.00481	0.00974	CcSEcCtD
Loxapine—Cerebrovascular accident—Irinotecan—colon cancer	0.00471	0.00954	CcSEcCtD
Loxapine—CHRM3—smooth muscle tissue—colon cancer	0.00456	0.00912	CbGeAlD
Loxapine—HTR7—epithelium—colon cancer	0.0045	0.00901	CbGeAlD
Loxapine—Urinary retention—Vincristine—colon cancer	0.0045	0.00913	CcSEcCtD
Loxapine—Dysarthria—Capecitabine—colon cancer	0.0045	0.00911	CcSEcCtD
Loxapine—CHRM3—renal system—colon cancer	0.00439	0.00878	CbGeAlD
Loxapine—HTR1A—renal system—colon cancer	0.00437	0.00874	CbGeAlD
Loxapine—Gait disturbance—Capecitabine—colon cancer	0.00436	0.00883	CcSEcCtD
Loxapine—ADRA1A—epithelium—colon cancer	0.00434	0.00869	CbGeAlD
Loxapine—HTR7—smooth muscle tissue—colon cancer	0.00434	0.00868	CbGeAlD
Loxapine—Orthostatic hypotension—Irinotecan—colon cancer	0.00421	0.00854	CcSEcCtD
Loxapine—HTR7—renal system—colon cancer	0.00418	0.00836	CbGeAlD
Loxapine—SLC6A4—digestive system—colon cancer	0.00404	0.00808	CbGeAlD
Loxapine—ADRA1A—renal system—colon cancer	0.00403	0.00806	CbGeAlD
Loxapine—Dry eye—Capecitabine—colon cancer	0.00393	0.00796	CcSEcCtD
Loxapine—HRH2—lymph node—colon cancer	0.00385	0.0077	CbGeAlD
Loxapine—ADRA2C—renal system—colon cancer	0.00384	0.00768	CbGeAlD
Loxapine—Dysphagia—Fluorouracil—colon cancer	0.00382	0.00774	CcSEcCtD
Loxapine—Photosensitivity reaction—Vincristine—colon cancer	0.00374	0.00757	CcSEcCtD
Loxapine—Weight decreased—Vincristine—colon cancer	0.0037	0.00751	CcSEcCtD
Loxapine—Weight decreased—Irinotecan—colon cancer	0.00361	0.00731	CcSEcCtD
Loxapine—CHRM3—digestive system—colon cancer	0.0036	0.0072	CbGeAlD
Loxapine—Photosensitivity—Capecitabine—colon cancer	0.00351	0.00713	CcSEcCtD
Loxapine—Renal failure—Irinotecan—colon cancer	0.00349	0.00708	CcSEcCtD
Loxapine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00348	0.00707	CcSEcCtD
Loxapine—Jaundice—Irinotecan—colon cancer	0.00346	0.00702	CcSEcCtD
Loxapine—HTR2A—embryo—colon cancer	0.00344	0.00688	CbGeAlD
Loxapine—HTR7—digestive system—colon cancer	0.00343	0.00685	CbGeAlD
Loxapine—HRH1—epithelium—colon cancer	0.00336	0.00673	CbGeAlD
Loxapine—Dysarthria—Methotrexate—colon cancer	0.00335	0.00679	CcSEcCtD
Loxapine—ADRA1A—lymphoid tissue—colon cancer	0.00335	0.00669	CbGeAlD
Loxapine—Hypoaesthesia—Vincristine—colon cancer	0.00326	0.00661	CcSEcCtD
Loxapine—HRH1—smooth muscle tissue—colon cancer	0.00324	0.00648	CbGeAlD
Loxapine—Agranulocytosis—Fluorouracil—colon cancer	0.00318	0.00644	CcSEcCtD
Loxapine—Cerebrovascular accident—Capecitabine—colon cancer	0.00315	0.00639	CcSEcCtD
Loxapine—Hypoaesthesia—Fluorouracil—colon cancer	0.00304	0.00616	CcSEcCtD
Loxapine—Angiopathy—Vincristine—colon cancer	0.00297	0.00603	CcSEcCtD
Loxapine—Mediastinal disorder—Vincristine—colon cancer	0.00295	0.00599	CcSEcCtD
Loxapine—Urinary retention—Capecitabine—colon cancer	0.00293	0.00595	CcSEcCtD
Loxapine—Alopecia—Vincristine—colon cancer	0.00289	0.00587	CcSEcCtD
Loxapine—Angiopathy—Irinotecan—colon cancer	0.00289	0.00587	CcSEcCtD
Loxapine—Mediastinal disorder—Irinotecan—colon cancer	0.00288	0.00583	CcSEcCtD
Loxapine—Gynaecomastia—Methotrexate—colon cancer	0.00283	0.00574	CcSEcCtD
Loxapine—Alopecia—Irinotecan—colon cancer	0.00282	0.00572	CcSEcCtD
Loxapine—Orthostatic hypotension—Capecitabine—colon cancer	0.00282	0.00572	CcSEcCtD
Loxapine—HTR2A—epithelium—colon cancer	0.00281	0.00562	CbGeAlD
Loxapine—ADRA2C—vagina—colon cancer	0.00278	0.00556	CbGeAlD
Loxapine—HTR2A—smooth muscle tissue—colon cancer	0.00271	0.00541	CbGeAlD
Loxapine—Alopecia—Fluorouracil—colon cancer	0.0027	0.00547	CcSEcCtD
Loxapine—Muscle spasms—Irinotecan—colon cancer	0.00267	0.00541	CcSEcCtD
Loxapine—Dysphagia—Capecitabine—colon cancer	0.00267	0.00541	CcSEcCtD
Loxapine—Bronchospasm—Capecitabine—colon cancer	0.00262	0.00532	CcSEcCtD
Loxapine—Agitation—Vincristine—colon cancer	0.00262	0.00531	CcSEcCtD
Loxapine—Photosensitivity—Methotrexate—colon cancer	0.00262	0.00531	CcSEcCtD
Loxapine—HTR2A—renal system—colon cancer	0.00261	0.00521	CbGeAlD
Loxapine—HRH1—digestive system—colon cancer	0.00256	0.00512	CbGeAlD
Loxapine—HTR7—liver—colon cancer	0.00255	0.00511	CbGeAlD
Loxapine—Leukopenia—Vincristine—colon cancer	0.00255	0.00518	CcSEcCtD
Loxapine—Vision blurred—Fluorouracil—colon cancer	0.00251	0.00508	CcSEcCtD
Loxapine—Syncope—Irinotecan—colon cancer	0.00249	0.00505	CcSEcCtD
Loxapine—Leukopenia—Irinotecan—colon cancer	0.00249	0.00504	CcSEcCtD
Loxapine—Convulsion—Vincristine—colon cancer	0.00247	0.00501	CcSEcCtD
Loxapine—ADRA1A—liver—colon cancer	0.00246	0.00493	CbGeAlD
Loxapine—Hypertension—Vincristine—colon cancer	0.00246	0.00499	CcSEcCtD
Loxapine—Loss of consciousness—Irinotecan—colon cancer	0.00244	0.00495	CcSEcCtD
Loxapine—Photosensitivity reaction—Capecitabine—colon cancer	0.00243	0.00494	CcSEcCtD
Loxapine—Weight increased—Capecitabine—colon cancer	0.00243	0.00492	CcSEcCtD
Loxapine—Cough—Irinotecan—colon cancer	0.00242	0.00491	CcSEcCtD
Loxapine—Weight decreased—Capecitabine—colon cancer	0.00241	0.00489	CcSEcCtD
Loxapine—Hypertension—Irinotecan—colon cancer	0.0024	0.00486	CcSEcCtD
Loxapine—Leukopenia—Fluorouracil—colon cancer	0.00238	0.00483	CcSEcCtD
Loxapine—ADRA2C—liver—colon cancer	0.00235	0.00469	CbGeAlD
Loxapine—Cerebrovascular accident—Methotrexate—colon cancer	0.00234	0.00475	CcSEcCtD
Loxapine—Renal failure—Capecitabine—colon cancer	0.00234	0.00474	CcSEcCtD
Loxapine—Oedema—Vincristine—colon cancer	0.00233	0.00472	CcSEcCtD
Loxapine—Jaundice—Capecitabine—colon cancer	0.00232	0.0047	CcSEcCtD
Loxapine—Convulsion—Fluorouracil—colon cancer	0.0023	0.00467	CcSEcCtD
Loxapine—Confusional state—Irinotecan—colon cancer	0.00229	0.00463	CcSEcCtD
Loxapine—Nervous system disorder—Vincristine—colon cancer	0.00228	0.00463	CcSEcCtD
Loxapine—Thrombocytopenia—Vincristine—colon cancer	0.00228	0.00462	CcSEcCtD
Loxapine—Oedema—Irinotecan—colon cancer	0.00227	0.0046	CcSEcCtD
Loxapine—Chest pain—Fluorouracil—colon cancer	0.00226	0.00459	CcSEcCtD
Loxapine—HRH1—vagina—colon cancer	0.00226	0.00452	CbGeAlD
Loxapine—Shock—Irinotecan—colon cancer	0.00223	0.00452	CcSEcCtD
Loxapine—Nervous system disorder—Irinotecan—colon cancer	0.00222	0.00451	CcSEcCtD
Loxapine—Agranulocytosis—Capecitabine—colon cancer	0.00222	0.0045	CcSEcCtD
Loxapine—ADRA2A—vagina—colon cancer	0.00222	0.00444	CbGeAlD
Loxapine—Thrombocytopenia—Irinotecan—colon cancer	0.00222	0.0045	CcSEcCtD
Loxapine—Confusional state—Fluorouracil—colon cancer	0.00219	0.00444	CcSEcCtD
Loxapine—Hypotension—Vincristine—colon cancer	0.00217	0.00441	CcSEcCtD
Loxapine—Oedema—Fluorouracil—colon cancer	0.00217	0.0044	CcSEcCtD
Loxapine—HTR2A—digestive system—colon cancer	0.00214	0.00427	CbGeAlD
Loxapine—Hepatitis—Capecitabine—colon cancer	0.00214	0.00433	CcSEcCtD
Loxapine—Nervous system disorder—Fluorouracil—colon cancer	0.00213	0.00432	CcSEcCtD
Loxapine—Thrombocytopenia—Fluorouracil—colon cancer	0.00213	0.00431	CcSEcCtD
Loxapine—Hypoaesthesia—Capecitabine—colon cancer	0.00212	0.00431	CcSEcCtD
Loxapine—Tachycardia—Fluorouracil—colon cancer	0.00212	0.0043	CcSEcCtD
Loxapine—Hypotension—Irinotecan—colon cancer	0.00212	0.00429	CcSEcCtD
Loxapine—Insomnia—Vincristine—colon cancer	0.0021	0.00427	CcSEcCtD
Loxapine—Paraesthesia—Vincristine—colon cancer	0.00209	0.00424	CcSEcCtD
Loxapine—Insomnia—Irinotecan—colon cancer	0.00205	0.00416	CcSEcCtD
Loxapine—Paraesthesia—Irinotecan—colon cancer	0.00204	0.00413	CcSEcCtD
Loxapine—SLC6A2—lymph node—colon cancer	0.00203	0.00406	CbGeAlD
Loxapine—Hypotension—Fluorouracil—colon cancer	0.00203	0.00411	CcSEcCtD
Loxapine—Dyspnoea—Irinotecan—colon cancer	0.00202	0.0041	CcSEcCtD
Loxapine—Somnolence—Irinotecan—colon cancer	0.00201	0.00409	CcSEcCtD
Loxapine—Gastrointestinal disorder—Vincristine—colon cancer	0.00201	0.00407	CcSEcCtD
Loxapine—Fatigue—Vincristine—colon cancer	0.00201	0.00407	CcSEcCtD
Loxapine—Constipation—Vincristine—colon cancer	0.00199	0.00404	CcSEcCtD
Loxapine—Insomnia—Fluorouracil—colon cancer	0.00196	0.00398	CcSEcCtD
Loxapine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00196	0.00397	CcSEcCtD
Loxapine—Fatigue—Irinotecan—colon cancer	0.00195	0.00396	CcSEcCtD
Loxapine—Paraesthesia—Fluorouracil—colon cancer	0.00195	0.00395	CcSEcCtD
Loxapine—Constipation—Irinotecan—colon cancer	0.00194	0.00393	CcSEcCtD
Loxapine—Angiopathy—Capecitabine—colon cancer	0.00194	0.00393	CcSEcCtD
Loxapine—Dyspnoea—Fluorouracil—colon cancer	0.00194	0.00392	CcSEcCtD
Loxapine—Somnolence—Fluorouracil—colon cancer	0.00193	0.00391	CcSEcCtD
Loxapine—Mediastinal disorder—Capecitabine—colon cancer	0.00192	0.0039	CcSEcCtD
Loxapine—HTR2A—vagina—colon cancer	0.00189	0.00377	CbGeAlD
Loxapine—Alopecia—Capecitabine—colon cancer	0.00189	0.00383	CcSEcCtD
Loxapine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00187	0.0038	CcSEcCtD
Loxapine—Feeling abnormal—Irinotecan—colon cancer	0.00187	0.00379	CcSEcCtD
Loxapine—Dysgeusia—Capecitabine—colon cancer	0.00182	0.00369	CcSEcCtD
Loxapine—Photosensitivity reaction—Methotrexate—colon cancer	0.00181	0.00368	CcSEcCtD
Loxapine—ADRA2C—lymph node—colon cancer	0.0018	0.0036	CbGeAlD
Loxapine—Feeling abnormal—Fluorouracil—colon cancer	0.00179	0.00363	CcSEcCtD
Loxapine—Muscle spasms—Capecitabine—colon cancer	0.00179	0.00362	CcSEcCtD
Loxapine—Drowsiness—Methotrexate—colon cancer	0.00177	0.00359	CcSEcCtD
Loxapine—Vision blurred—Capecitabine—colon cancer	0.00175	0.00355	CcSEcCtD
Loxapine—Tremor—Capecitabine—colon cancer	0.00174	0.00353	CcSEcCtD
Loxapine—Renal failure—Methotrexate—colon cancer	0.00174	0.00353	CcSEcCtD
Loxapine—Hypersensitivity—Vincristine—colon cancer	0.00171	0.00348	CcSEcCtD
Loxapine—Hypersensitivity—Irinotecan—colon cancer	0.00167	0.00339	CcSEcCtD
Loxapine—Asthenia—Vincristine—colon cancer	0.00167	0.00339	CcSEcCtD
Loxapine—Syncope—Capecitabine—colon cancer	0.00167	0.00338	CcSEcCtD
Loxapine—Leukopenia—Capecitabine—colon cancer	0.00166	0.00337	CcSEcCtD
Loxapine—Agranulocytosis—Methotrexate—colon cancer	0.00165	0.00335	CcSEcCtD
Loxapine—Loss of consciousness—Capecitabine—colon cancer	0.00163	0.00331	CcSEcCtD
Loxapine—Asthenia—Irinotecan—colon cancer	0.00163	0.0033	CcSEcCtD
Loxapine—Cough—Capecitabine—colon cancer	0.00162	0.00329	CcSEcCtD
Loxapine—Hypertension—Capecitabine—colon cancer	0.0016	0.00325	CcSEcCtD
Loxapine—Hypersensitivity—Fluorouracil—colon cancer	0.0016	0.00324	CcSEcCtD
Loxapine—HTR2A—liver—colon cancer	0.00159	0.00318	CbGeAlD
Loxapine—Hepatitis—Methotrexate—colon cancer	0.00159	0.00322	CcSEcCtD
Loxapine—Chest pain—Capecitabine—colon cancer	0.00158	0.00321	CcSEcCtD
Loxapine—Dry mouth—Capecitabine—colon cancer	0.00155	0.00314	CcSEcCtD
Loxapine—Dizziness—Vincristine—colon cancer	0.00154	0.00312	CcSEcCtD
Loxapine—Pruritus—Fluorouracil—colon cancer	0.00154	0.00311	CcSEcCtD
Loxapine—Confusional state—Capecitabine—colon cancer	0.00153	0.0031	CcSEcCtD
Loxapine—Oedema—Capecitabine—colon cancer	0.00152	0.00308	CcSEcCtD
Loxapine—Dizziness—Irinotecan—colon cancer	0.0015	0.00304	CcSEcCtD
Loxapine—Shock—Capecitabine—colon cancer	0.00149	0.00303	CcSEcCtD
Loxapine—Nervous system disorder—Capecitabine—colon cancer	0.00149	0.00302	CcSEcCtD
Loxapine—Thrombocytopenia—Capecitabine—colon cancer	0.00149	0.00301	CcSEcCtD
Loxapine—Tachycardia—Capecitabine—colon cancer	0.00148	0.003	CcSEcCtD
Loxapine—Vomiting—Vincristine—colon cancer	0.00148	0.003	CcSEcCtD
Loxapine—Rash—Vincristine—colon cancer	0.00147	0.00298	CcSEcCtD
Loxapine—Dermatitis—Vincristine—colon cancer	0.00147	0.00297	CcSEcCtD
Loxapine—HRH1—lymph node—colon cancer	0.00146	0.00292	CbGeAlD
Loxapine—Headache—Vincristine—colon cancer	0.00146	0.00296	CcSEcCtD
Loxapine—Angiopathy—Methotrexate—colon cancer	0.00144	0.00292	CcSEcCtD
Loxapine—Vomiting—Irinotecan—colon cancer	0.00144	0.00292	CcSEcCtD
Loxapine—ADRA2A—lymph node—colon cancer	0.00144	0.00287	CbGeAlD
Loxapine—Dizziness—Fluorouracil—colon cancer	0.00144	0.00291	CcSEcCtD
Loxapine—Mediastinal disorder—Methotrexate—colon cancer	0.00143	0.0029	CcSEcCtD
Loxapine—Rash—Irinotecan—colon cancer	0.00143	0.0029	CcSEcCtD
Loxapine—Dermatitis—Irinotecan—colon cancer	0.00143	0.00289	CcSEcCtD
Loxapine—Headache—Irinotecan—colon cancer	0.00142	0.00288	CcSEcCtD
Loxapine—Hypotension—Capecitabine—colon cancer	0.00142	0.00287	CcSEcCtD
Loxapine—Alopecia—Methotrexate—colon cancer	0.0014	0.00285	CcSEcCtD
Loxapine—Nausea—Vincristine—colon cancer	0.00138	0.0028	CcSEcCtD
Loxapine—Vomiting—Fluorouracil—colon cancer	0.00138	0.0028	CcSEcCtD
Loxapine—Insomnia—Capecitabine—colon cancer	0.00137	0.00278	CcSEcCtD
Loxapine—Rash—Fluorouracil—colon cancer	0.00137	0.00278	CcSEcCtD
Loxapine—Dermatitis—Fluorouracil—colon cancer	0.00137	0.00277	CcSEcCtD
Loxapine—Paraesthesia—Capecitabine—colon cancer	0.00136	0.00276	CcSEcCtD
Loxapine—Headache—Fluorouracil—colon cancer	0.00136	0.00276	CcSEcCtD
Loxapine—Dysgeusia—Methotrexate—colon cancer	0.00135	0.00275	CcSEcCtD
Loxapine—Dyspnoea—Capecitabine—colon cancer	0.00135	0.00274	CcSEcCtD
Loxapine—Nausea—Irinotecan—colon cancer	0.00135	0.00273	CcSEcCtD
Loxapine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00131	0.00266	CcSEcCtD
Loxapine—Fatigue—Capecitabine—colon cancer	0.00131	0.00265	CcSEcCtD
Loxapine—Vision blurred—Methotrexate—colon cancer	0.0013	0.00264	CcSEcCtD
Loxapine—Constipation—Capecitabine—colon cancer	0.0013	0.00263	CcSEcCtD
Loxapine—Nausea—Fluorouracil—colon cancer	0.00129	0.00261	CcSEcCtD
Loxapine—Azelastine—ABCB1—colon cancer	0.00127	0.184	CrCbGaD
Loxapine—Feeling abnormal—Capecitabine—colon cancer	0.00125	0.00253	CcSEcCtD
Loxapine—Leukopenia—Methotrexate—colon cancer	0.00124	0.00251	CcSEcCtD
Loxapine—Cough—Methotrexate—colon cancer	0.00121	0.00245	CcSEcCtD
Loxapine—Convulsion—Methotrexate—colon cancer	0.0012	0.00243	CcSEcCtD
Loxapine—Chest pain—Methotrexate—colon cancer	0.00118	0.00239	CcSEcCtD
Loxapine—Confusional state—Methotrexate—colon cancer	0.00114	0.00231	CcSEcCtD
Loxapine—Hypersensitivity—Capecitabine—colon cancer	0.00112	0.00227	CcSEcCtD
Loxapine—Nervous system disorder—Methotrexate—colon cancer	0.00111	0.00225	CcSEcCtD
Loxapine—Thrombocytopenia—Methotrexate—colon cancer	0.00111	0.00224	CcSEcCtD
Loxapine—Asthenia—Capecitabine—colon cancer	0.00109	0.00221	CcSEcCtD
Loxapine—Olanzapine—ABCB1—colon cancer	0.00109	0.158	CrCbGaD
Loxapine—Pruritus—Capecitabine—colon cancer	0.00107	0.00218	CcSEcCtD
Loxapine—Hypotension—Methotrexate—colon cancer	0.00106	0.00214	CcSEcCtD
Loxapine—Trazodone—ABCB1—colon cancer	0.00105	0.153	CrCbGaD
Loxapine—Insomnia—Methotrexate—colon cancer	0.00102	0.00207	CcSEcCtD
Loxapine—Paraesthesia—Methotrexate—colon cancer	0.00101	0.00206	CcSEcCtD
Loxapine—Dyspnoea—Methotrexate—colon cancer	0.00101	0.00204	CcSEcCtD
Loxapine—Somnolence—Methotrexate—colon cancer	0.001	0.00204	CcSEcCtD
Loxapine—Dizziness—Capecitabine—colon cancer	0.001	0.00203	CcSEcCtD
Loxapine—Clobazam—ABCB1—colon cancer	0.000984	0.143	CrCbGaD
Loxapine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000975	0.00198	CcSEcCtD
Loxapine—Fatigue—Methotrexate—colon cancer	0.000974	0.00197	CcSEcCtD
Loxapine—Vomiting—Capecitabine—colon cancer	0.000964	0.00196	CcSEcCtD
Loxapine—Rash—Capecitabine—colon cancer	0.000956	0.00194	CcSEcCtD
Loxapine—Dermatitis—Capecitabine—colon cancer	0.000956	0.00194	CcSEcCtD
Loxapine—Headache—Capecitabine—colon cancer	0.00095	0.00193	CcSEcCtD
Loxapine—Feeling abnormal—Methotrexate—colon cancer	0.000931	0.00189	CcSEcCtD
Loxapine—Nausea—Capecitabine—colon cancer	0.000901	0.00183	CcSEcCtD
Loxapine—Hypersensitivity—Methotrexate—colon cancer	0.000832	0.00169	CcSEcCtD
Loxapine—Asthenia—Methotrexate—colon cancer	0.00081	0.00164	CcSEcCtD
Loxapine—Pruritus—Methotrexate—colon cancer	0.000799	0.00162	CcSEcCtD
Loxapine—Dizziness—Methotrexate—colon cancer	0.000747	0.00151	CcSEcCtD
Loxapine—Vomiting—Methotrexate—colon cancer	0.000718	0.00146	CcSEcCtD
Loxapine—Rash—Methotrexate—colon cancer	0.000712	0.00144	CcSEcCtD
Loxapine—Dermatitis—Methotrexate—colon cancer	0.000711	0.00144	CcSEcCtD
Loxapine—Headache—Methotrexate—colon cancer	0.000707	0.00143	CcSEcCtD
Loxapine—Trifluoperazine—ABCB1—colon cancer	0.00068	0.099	CrCbGaD
Loxapine—Nausea—Methotrexate—colon cancer	0.000671	0.00136	CcSEcCtD
Loxapine—Quetiapine—ABCB1—colon cancer	0.000659	0.0961	CrCbGaD
Loxapine—Diazepam—ABCB1—colon cancer	0.000574	0.0837	CrCbGaD
Loxapine—Clozapine—ABCB1—colon cancer	0.000567	0.0826	CrCbGaD
